Immunotherapy, using the body’s own immune system to target and destroy cancer cells, is one of the most promising frontiers in cancer research, but many patients do not respond to the therapies for reasons not fully understood. Scientists at the Yale Systems Biology Institute have taken a step closer to understanding how the genetic makeup of cancer cells directs the […]

Continue reading »